Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Rocca

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|September 28, 2020
Pyrrolo[2',3':3,4]cyclohepta[1,2-<i>d</i>][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell TypesVirginia Spanò, Roberta Rocca, Marilia Barreca, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative PropertiesRoberta Rocca, Francesca Scionti, Matteo Nadai, et al.
European Journal of Medicinal Chemistry|August 26, 2019
Targeting multiple G-quadruplex-forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivativesRaffaella Catalano, Federica Moraca, Jussara Amato, et al.
Blood|August 19, 2024
An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myelomaKatia Grillone, Serena Ascrizzi, Paolo Cremaschi, et al.
International Journal of Molecular Sciences|September 23, 2022
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple MyelomaKatia Grillone, Caterina Riillo, Roberta Rocca, et al.
European Journal of Medicinal Chemistry|August 24, 2019
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activityFrancesca Esposito, Francesca Alessandra Ambrosio, Rita Maleddu, et al.
Bioorganic Chemistry|September 2, 2023
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activityCarla Barbaraci, Viviana di Giacomo, Annalisa Maruca, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 26, 2023
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myelomaFrancesca Scionti, Giada Juli, Roberta Rocca, et al.
Cancers|February 6, 2020
The Non-Coding RNA Landscape of Plasma Cell DyscrasiasEugenio Morelli, Annamaria Gullà, Roberta Rocca, et al.
Journal of Translational Medicine|October 23, 2022
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid RhamnetinDaniele Caracciolo, Giada Juli, Caterina Riillo, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|September 28, 2020
Pyrrolo[2',3':3,4]cyclohepta[1,2-<i>d</i>][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell TypesVirginia Spanò, Roberta Rocca, Marilia Barreca, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative PropertiesRoberta Rocca, Francesca Scionti, Matteo Nadai, et al.
European Journal of Medicinal Chemistry|August 26, 2019
Targeting multiple G-quadruplex-forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivativesRaffaella Catalano, Federica Moraca, Jussara Amato, et al.
Blood|August 19, 2024
An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myelomaKatia Grillone, Serena Ascrizzi, Paolo Cremaschi, et al.
International Journal of Molecular Sciences|September 23, 2022
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple MyelomaKatia Grillone, Caterina Riillo, Roberta Rocca, et al.
European Journal of Medicinal Chemistry|August 24, 2019
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activityFrancesca Esposito, Francesca Alessandra Ambrosio, Rita Maleddu, et al.
Bioorganic Chemistry|September 2, 2023
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activityCarla Barbaraci, Viviana di Giacomo, Annalisa Maruca, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 26, 2023
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myelomaFrancesca Scionti, Giada Juli, Roberta Rocca, et al.
Cancers|February 6, 2020
The Non-Coding RNA Landscape of Plasma Cell DyscrasiasEugenio Morelli, Annamaria Gullà, Roberta Rocca, et al.
Journal of Translational Medicine|October 23, 2022
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid RhamnetinDaniele Caracciolo, Giada Juli, Caterina Riillo, et al.
Pageof 8